AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,256,000 | +476.1% | 83,004 | +461.4% | 0.04% | +275.0% |
| Q2 2020 | $218,000 | +48.3% | 14,786 | +35.6% | 0.01% | +20.0% |
| Q1 2020 | $147,000 | -69.5% | 10,906 | -45.3% | 0.01% | -44.4% |
| Q4 2019 | $482,000 | +6785.7% | 19,945 | +8351.3% | 0.02% | – |
| Q2 2019 | $7,000 | -99.5% | 236 | -99.1% | 0.00% | -100.0% |
| Q1 2019 | $1,274,000 | +149.3% | 26,813 | +89.5% | 0.07% | +111.8% |
| Q4 2018 | $511,000 | -74.9% | 14,152 | -57.2% | 0.03% | -71.2% |
| Q3 2018 | $2,036,000 | -23.3% | 33,072 | -15.9% | 0.12% | -29.8% |
| Q2 2018 | $2,656,000 | -14.0% | 39,318 | -30.9% | 0.17% | -25.0% |
| Q1 2018 | $3,089,000 | +61.7% | 56,941 | +78.1% | 0.22% | +46.4% |
| Q4 2017 | $1,910,000 | +122.6% | 31,967 | +81.0% | 0.15% | +98.7% |
| Q3 2017 | $858,000 | +10.3% | 17,661 | +19.3% | 0.08% | +4.1% |
| Q2 2017 | $778,000 | -26.5% | 14,803 | -36.6% | 0.07% | -26.7% |
| Q1 2017 | $1,058,000 | -9.0% | 23,337 | -24.0% | 0.10% | -27.9% |
| Q4 2016 | $1,162,000 | -52.8% | 30,689 | -53.0% | 0.14% | -45.7% |
| Q3 2016 | $2,462,000 | +617.8% | 65,228 | +496.5% | 0.26% | +437.5% |
| Q1 2015 | $343,000 | – | 10,936 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|